Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Dörr, Jacob
DOB: 10-JUN-1953 (Age: 72)
Gender: male
ID: 1494-404003-0 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 21-JUN-2025

Problem list

Condition Onset Date Status
Ischemic heart disease 09-Mar-2008 active
Hyperlipidemia 05-Jan-1996 active
Essential hypertension 25-Nov-1988 active
Metabolic syndrome X 25-Nov-1988 active
Anemia 28-Sep-1984 active
Prediabetes 04-Feb-1983 active

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 20-Jun-2025
SARS-CoV-2 mRNA vaccine 09-Apr-2021
Clostridium tetani toxoid antigen adsorbed only vaccine product 22-May-2020

Procedure History list

Procedure Date Reason
Depression screening 22-Jan-2021 -
Assessment of health and social care needs 22-Jan-2021 -
Screening for drug abuse 22-Jan-2021 -
Assessment using Morse Fall Scale 22-Jan-2021 -
Assessment of substance use 22-Jan-2021 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 22-Jan-2021 -
Referral to home health care service 22-Jul-2016 -
Pre-discharge assessment 10-Jul-2016 -
Discharge from skilled nursing facility (procedure) 10-Jul-2016 -
Professional / ancillary services care 09-Jul-2016 -
Nursing care/supplementary surveillance 09-Jul-2016 -
Care regimes assessment 06-Jul-2016 -
History AND physical examination 03-Jul-2016 -
Occupational therapy 03-Jul-2016 -
Initial patient assessment 03-Jul-2016 -
Development of individualized plan of care 03-Jul-2016 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Hyperlipidemia clinical management plan 26-Jan-1996 Hyperlipidemia
  • Achieve and maintain LDL cholesterol below 70 mg/dL
  • Achieve and maintain total cholesterol below 150 mg/dL
  • Maintain HDL cholesterol above 40 mg/dL
  • Achieve and maintain triglycerides below 150 mg/dL
Lifestyle education regarding hypertension 25-Nov-1988 Essential hypertension (disorder)
  • Achieve and maintain systolic blood pressure below 130 mm[Hg] through lifestyle modifications.
  • Achieve and maintain diastolic blood pressure below 80 mm[Hg] through lifestyle modifications.
  • Reduce daily sodium intake to less than 2.3 g per day as part of hypertension management.
  • Engage in at least 150 minutes of moderate-intensity aerobic physical activity per week to support blood pressure control.
  • Achieve a 5% reduction in body weight to support blood pressure control.
Diabetes self management plan 04-Feb-1983 Prediabetes
  • Patient will verbalize understanding of prediabetes, healthy eating, physical activity, and blood glucose monitoring as part of diabetes self-management.
  • Maintain hemoglobin A1c below 6.5% to prevent progression to diabetes.
  • Achieve and maintain at least 5% weight loss from baseline to reduce risk of diabetes progression.
  • Engage in at least 150 minutes per week of moderate-intensity physical activity.
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-06-20 2024-06-14
Body Height 185.6 cm 185.6 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} 3 {score}
Body Weight 104.2 kg 104.2 kg
Body mass index (BMI) [Ratio] 30.3 kg/m2 30.3 kg/m2
Diastolic Blood Pressure 65 mm[Hg] 62 mm[Hg]
Systolic Blood Pressure 107 mm[Hg] 102 mm[Hg]
Heart rate 60 /min 66 /min
Respiratory rate 13 /min 15 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 21-JUN-2025 Reference Range Unit
Glucose [Mass/volume] in Blood 99.0 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 16.8 7 - 50 mg/dL
Creatinine [Mass/volume] in Blood 2.6 H 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.0 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 139.1 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.0 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 104.9 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 27.1 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 7.4 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.6 3.5 - 5.5 g/dL
Globulin [Mass/volume] in Serum by calculation 2.5 2 - 3.5 g/L
Bilirubin.total [Mass/volume] in Serum or Plasma 1.2 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 81.4 53 - 130 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 59.5 7 - 63 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18.3 10 - 40 U/L
Cholesterol [Mass/volume] in Serum or Plasma 200.7 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 196.5 10 - 200 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 113.9 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 56.7 40 - 100 mg/dL

Device Use

Device Date (since)
Blood glucose meter (physical object) 04-Feb-1983